arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Palvella Therapeutics, Inc.

PVLA Health Care Biotechnology: Pharmaceutical Preparations
$108.67
▼ -5.4% Today
as of Jun 7, 07:25 ET
Last 30 days -13.73% Apr 28 → Jun 05
$102.63 $110.02 $117.42 $124.81 $132.21 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$112.00
High
$114.48
Low
$105.62
Volume
$369,442
Avg Vol
$229,456
Mkt Cap
$1.7B
P/E (TTM)
Beta
52w High
$151.18
52w Low
$20.20
Div Yield
Shares Out
$14M

Overview

52-week range
$20
$151
68% of range
Avg surprise (last 2)
+22.5%
Avg reaction (last 2)
-6.7%
0% positive
Latest IV / EM
75%
EM ±10.4% · $110 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-8.70$-5.62$-2.54$0.54$3.62 Actual $3.62Actual $-8.70Actual $-1.54Actual $-2.47Actual $-3.94Actual $-0.74Est $-3.40Actual $-0.86Actual $-1.03Actual $-1.20Est $-0.90 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-16M$-13M$-10M$-7M$-4M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 7, 2026Mar/2026 $-1.20 $-0.90 -33.3% -62.2% -13.0% earnings
Tue Sep 30, 2025Sep 2025 $-1.03 financials
Mon Jun 30, 2025Jun 2025 $-0.86 financials
Thu May 15, 2025Mar/2025 $-0.74 $-3.40 +78.2% -0.4% earnings
Mon Sep 30, 2024Sep 2024 $-3.94 financials
Sun Jun 30, 2024Jun 2024 $-2.47 financials
Sun Mar 31, 2024Mar 2024 $-1.54 financials
Sat Sep 30, 2023Sep 2023 $-8.70 financials
Fri Jun 30, 2023Jun 2023 $3.62 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-15M$-10M$-9M$-8M$-5M$-3M
Net income$-16M$-11M$-9M$-8M$-7M$-4M
EPS (diluted)$-1.20$-1.03$-0.86$-0.74$-3.94$-2.47

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$206M$58M$64M$70M$76M$84M$19M$20M
Inventory
Total current assets$263M$59M$67M$74M$79M$88M
Total assets$264M$60M$67M$74M$79M$88M$21M$25M
Long-term debt
Total liabilities$31M$32M$28M$26M$24M$26M
Total equity$232M$28M$39M$48M$56M$63M$-87M$-81M

Implied volatility — last 90 days

69%72%74%77%79% Jun 07 — IV 75% · EM ±10.4%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.